Evidence map›Paper›PMID 34552684›Full record

ArticleThe journal of physical chemistry. C, Nanomaterials and interfaces2020

Luminescence Onset and Mechanism of the Formation of Gold(I)-Thiolate Complexes as the Precursors to Nanoparticles.

Gabriel A Palermo, Mehnaz Tarannum, Shunji Egusa

Abstract read
In one paragraph

Article in The journal of physical chemistry. C, Nanomaterials and interfaces, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gabriel A PalermoDepartment of Physics and Optical Science, Center for Biomedical Engineering & Science, The University of North Carolina, Charlotte, North Carolina 28223, United States.
Mehnaz TarannumDepartment of Physics and Optical Science, Center for Biomedical Engineering & Science, The University of North Carolina, Charlotte, North Carolina 28223, United States.
Shunji EgusaDepartment of Physics and Optical Science, Center for Biomedical Engineering & Science, The University of North Carolina, Charlotte, North Carolina 28223, United States.ORCID 0000-0003-4817-3317

Funding

Evaluating a simple nanochemistry for lineage-targeted drug deliveryR15GM129678 · NIGMS · UNIVERSITY OF NORTH CAROLINA CHARLOTTE · PI EGUSA, SHUNJI · 2018 to 2018
$440k
NIGMS NIH HHS R15 GM129678
6 · The paper itself

Abstract

Gold(I) (Au(I))-thiolate complexes are widely believed as the precursors to Au nanoparticle formations. While the literature suggests that the Au(III)-to-thiol ligand stoichiometric ratio of 1:3 is required to reduce a Au(III) and yield a Au(I)-thiolate, other stoichiometric ratios are also known to produce Au nanoparticles upon reduction. Using the characteristic red luminescence of Au(I)-alkanethiolates, we examined the process of their formations and their implications on the Au nanoparticle synthesis in detail. The onset of the luminescence, correlated with the Au(I)-thiolate formation, as well as the kinetics of the luminophore formation were evaluated in terms of the Au(III)-to-alkanethiol ratios. The onset of the luminescence was affected significantly by the solvent polarity during reaction but not post reaction. We found that the kinetics of the luminophore formation can vary widely, requiring from minutes to 24 h for completion depending on the thiol ligands and molar ratios, as well as solvents. This information could help in designing Au nanoparticle syntheses with the logical choice of Au(III)-to-thiol ratio, solvent, and the timing of reduction.

Identifiers

PMID34552684
PMCPMC8455096

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.